Business
COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update
COSCIENS voluntarily delists from Nasdaq, while retaining the Company’s listing on the TSX...
About this update from Cosciens Biopharma Inc.
[{"type":"text","content":"COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update\n\n\n\n\n COSCIENS voluntarily delists from Nasdaq, while retaining the Company’s listing on the TSX\n \n\n\n\n COSCIENS restructuring results in significantly lower cash outflow with operating expenses down 59% vs. Q3 2024.\n \n\n\n\n TORONTO, ONTARIO, Nov. 11, 2025 (GLOBE NEWSWIRE) --\n \n COSCIENS Biopharma Inc. (FINRA: CSCIF) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and pharmaceutical solutions, today reported its financial and operating results for the third quarter ended September 30, 2025 and provided a corporate update regarding operational and strategic developments during the quarter.\n \n\n “Our focus in Q3 was to ensure the zero-based budgeting and restructuring plans we designed were executed successfully to establish our go forward cost structure,” said Anna Biehn, Chief Executive Officer of COSCIENS. “Management and the Board are encouraged with the early results and have made significant progress in an assessment of the existing projects, business development efforts and future growth opportunities.”\n \n\n\n Focus on Revenue-Generating Base Business\n \n\n\n Stabilizing the core business continues to be a strong priority and management implemented measures to drive discipline in base business management, forecasting and an end-to-end procurement to manufacturing review. As a result, Q3 gross margins showed an improvement of 700 basis points over the previous quarter, driven by both cost cuts and operational improvements.\n \n\n\n Cost Structure Reset and Zero-Based Budgeting\n \n\n\n The Company launched a zero-based budgeting (ZBB) initiative in Q2 to improve the efficiency of the organizational structure. The initiative included reduction in headcount and was implemented to further align costs with strategic priorities. The cost reset and restructuring initiative began showing results in Q3 with overall operating expenses down 59% vs. Q3 2024 resulting in significantly lower cash outflow for the quarter. The business will continue to seek lower operating costs as the discipline continues.\n \n\n\n Nasdaq Delisting – Continued Listing on TSX– Application for quotation on ...